Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Latrophilins (LAT-1 and LAT-2) are adhesion G-protein-coupled receptors (GPCRs) crucial for cell signaling, synapse formation, and tissue polarity. LAT-1 is primarily brain-specific and involved in synapse maturation and exocytosis. LAT-2 is ubiquitously expressed and implicated in breast cancer biology and postsynaptic target recognition. Both interact with ligands like alpha-latrotoxin and teneurins, activating G-protein pathways and influencing calcium release. In C. elegans, LAT-1 is vital for establishing anterior-posterior tissue polarity.
Ligand binding induces receptor reassociation, activating intracellular G-protein–mediated pathways and releasing Ca²⁺ from internal stores, leading to neurotransmitter or hormone secretion/exocytosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Latrophilin Receptor LAT-1/LAT-2 (LPHN1/LAT-1 & LPHN2/LAT-2).